Report cover image

Human Embryonic Stem Cells Market Growth, Size and Trends Analysis - By Application - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Feb 10, 2025
Length 260 Pages
SKU # SPER19805268

Description

Human Embryonic Stem Cells Market Introduction and Overview

According to SPER market research, ‘Human Embryonic Stem Cells Market Size- By Application – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Human Embryonic Stem Cells Market is predicted to reach 6.1 billion by 2034 with a CAGR of 10.73%.

Human embryonic stem cells (hESCs) are Pluripotent cells produced from the inner cell mass of blastocysts, which are early-stage embryos that form five to seven days after fertilization. These cells are extremely useful in regenerative medicine and scientific study because of their exceptional capacity to self-renew indefinitely and specialize into any type of cell found in the human body, including blood, muscle, and nerve cells.

Restraints: Despite its potential, the market for human embryonic stem cells is beset with difficulties. Strict regulatory frameworks resulting from ethical concerns over the use of embryos in research impede advancement. Therapeutic uses are further complicated by technical issues like the possibility of teratoma development and immunological rejection. The market’s expansion is also impacted by public misperceptions and resistance, as well as competition from other stem cell sources including induced pluripotent stem cells (iPSCs).

Scope of the Report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered By Application.

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered

Thermo Fisher Scientific, Inc., STEMCELL Technologies, Merck KGaA, CellGenix GmbH, PromoCell GmbH, Takara Bio, Lonza, ATCC, Cellartis AB, Accegen, Cell Applications, Inc., Bio-Techne. and others.

Human Embryonic Stem Cells Market Segmentation:

By Application: Based on the Application, Global Human Embryonic Stem Cells Market is segmented as; Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe and Middle East & Africa.

Table of Contents

260 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Human Embryonic Stem Cells Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Human Embryonic Stem Cells Market
7. Global Human Embryonic Stem Cells Market, By Application (USD Million) 2021-2034
7.1. Regenerative Medicine
7.2. Stem Cell Biology Research
7.3. Tissue Engineering
7.4. Toxicology Testing
8. Global Human Embryonic Stem Cells Market, (USD Million) 2021-2034
8.1. Global Human Embryonic Stem Cells Market Size and Market Share
9. Global Human Embryonic Stem Cells Market, By Region, (USD Million) 2021-2034
9.1. Asia-Pacific
9.1.1. Australia
9.1.2. China
9.1.3. India
9.1.4. Japan
9.1.5. South Korea
9.1.6. Rest of Asia-Pacific
9.2. Europe
9.2.1. France
9.2.2. Germany
9.2.3. Italy
9.2.4. Spain
9.2.5. United Kingdom
9.2.6. Rest of Europe
9.3. Middle East and Africa
9.3.1. Kingdom of Saudi Arabia
9.3.2. United Arab Emirates
9.3.3. Qatar
9.3.4. South Africa
9.3.5. Egypt
9.3.6. Morocco
9.3.7. Nigeria
9.3.8. Rest of Middle-East and Africa
9.4. North America
9.4.1. Canada
9.4.2. Mexico
9.4.3. United States
9.5. Latin America
9.5.1. Argentina
9.5.2. Brazil
9.5.3. Rest of Latin America
10. Company Profile
10.1. Thermo Fisher Scientific, Inc.
10.1.1. Company details
10.1.2. Financial outlook
10.1.3. Product summary
10.1.4. Recent developments
10.2. STEMCELL Technologies
10.2.1. Company details
10.2.2. Financial outlook
10.2.3. Product summary
10.2.4. Recent developments
10.3. Merck KGaA
10.3.1. Company details
10.3.2. Financial outlook
10.3.3. Product summary
10.3.4. Recent developments
10.4. Sartorius AG
10.4.1. Company details
10.4.2. Financial outlook
10.4.3. Product summary
10.4.4. Recent developments
10.5. PromoCell GmBH
10.5.1. Company details
10.5.2. Financial outlook
10.5.3. Product summary
10.5.4. Recent developments
10.6. Takara Bio
10.6.1. Company details
10.6.2. Financial outlook
10.6.3. Product summary
10.6.4. Recent developments
10.7. Lonza
10.7.1. Company details
10.7.2. Financial outlook
10.7.3. Product summary
10.7.4. Recent developments
10.8. Cellartis AB
10.8.1. Company details
10.8.2. Financial outlook
10.8.3. Product summary
10.8.4. Recent developments
10.9. ATCC
10.9.1. Company details
10.9.2. Financial outlook
10.9.3. Product summary
10.9.4. Recent developments
10.10. AcceGen
10.10.1. Company details
10.10.2. Financial outlook
10.10.3. Product summary
10.10.4. Recent developments
10.11. Others
11. Conclusion
12. List of Abbreviations
13. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us